The results found that strong CD86 expression in primary CRC tumour was correlated with tumour differentiation, TNM stage and better RFS and OS of CRC patients, and strong CD163 expression in primary CRC tumour was associated with tumour differentiation, tumour size and worse RFS and OS of CRC patients. This evidence concerns the gene CD163 and colorectal carcinoma.